Key points are not available for this paper at this time.
Design
Guideline
Answers are grounded in this paper and cite their sources.
May limit routine aPTT/anti-Xa monitoring for heparin; challenges assumptions of reliable assay guidance in guidelines.
Limitations of the Laboratory Monitoring of Heparin Therapy - Scientific and Standardization Committee Communications: On behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis
No takes yet. Share an insight, caveat, or question.
M. Greaves (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: